Bone loss in hemophilia: new study measures the hidden risk
NCT ID NCT04384341
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at bone density in 448 men with hemophilia and healthy volunteers to see how common bone loss is. Participants had a bone density scan and some gave blood samples. The goal was to understand if hemophilia itself, not just lack of activity, leads to weaker bones.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHP - Bicêtre
Paris, France
-
BELGIUM - Brussels
Brussels, Belgium
-
CHU - Saint Eloi
Montpellier, 34295, France
-
CHU Caen
Caen, France
-
CHU Lille
Lille, France
-
CHU Nancy
Nancy, France
-
CHU de Nantes
Nantes, France
-
CHU de ROUEN
Rouen, France
-
CHU de Saint-Etienne
Saint-Etienne, 42055, France
-
Centre Hospitalier Metropole Savoie
Chambéry, 73000, France
-
Chu Brest Hopital Morvan
Brest, 29200, France
-
Chu Cth Estaing Clermont Ferrand
Clermont-Ferrand, France
-
Chu Grenoble Alpes
Grenoble, 38700, France
-
Chu La Timone Marseille
Marseille, 13010, France
-
Chu Necker Paris
Paris, 75015, France
-
Chu Rennes Hopital Pontchaillou
Rennes, 35000, France
-
Chu Strasbourg - Hôpital de Hautepierre
Strasbourg, France
-
Chu de Bordeaux
Bordeaux, 33076, France
-
Chu de Dijon
Dijon, 21000, France
-
HCL - Groupement Hospitalier Est (Hôpital Louis Pradel)
Bron, France
-
MHEK
Budapest, 1134, Hungary
-
ROMANIA - Bucharest
Bucharest, Romania
-
University Hospital Centre Zagreb
Zagreb, 10000, Croatia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Once-a-Week shot could transform hemophilia Care—Even for those with inhibitors
- Gene Editing's lasting impact: a 10-Year safety watch
- Can a single gene shot free hemophilia b patients from regular infusions?
- Can a clotting boost make surgery safer for hemophilia patients?
- Can a new clotting factor offer better bleed protection for severe hemophilia?
- A facelift without the bruising? tranexamic acid put to the test.